NCT/Study#

GSK3326595

A Phase I/II study to investigate the safety and clinical activity of GSK3326595 and other agents in subjects with myelodyplastic syndrome and acute myeloid leukaemia

A Phase I/II study to investigate the safety and clinical activity of GSK3326595 and other agents in subjects with myelodyplastic syndrome and acute myeloid leukaemia

DISEASE GROUP:
Leukemia
current phase:
Phase I/II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: